By otakuyassine3@gmail.com 
Doximity (NASDAQ:DOCS – Get Free Report) had its price target increased by stock analysts at The Goldman Sachs Group from $58.00 to $80.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. The Goldman Sachs Group’s price target would suggest a potential upside of 6.80% from the stock’s current price.
A number of other research analysts also recently weighed in on DOCS. KeyCorp decreased their price objective on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. Truist Financial upped their price target on shares of Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a research report on Thursday, November 14th. Leerink Partnrs upgraded shares of Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 7th. Piper Sandler upgraded shares of Doximity from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $31.00 to $78.00 in a report on Friday, February 7th. Finally, Stephens started coverage on shares of Doximity in a report on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price objective for the company. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $64.22.
Check Out Our Latest Stock Analysis on DOCS
Doximity Stock Performance
Shares of Doximity stock opened at $74.91 on Monday. The firm has a 50-day simple moving average of $56.61 and a two-hundred day simple moving average of $46.63. The company has a market cap of $13.98 billion, a P/E ratio of 74.91, a price-to-earnings-growth ratio of 4.61 and a beta of 1.39. Doximity has a fifty-two week low of $22.96 and a fifty-two week high of $85.21.
Insider Buying and Selling
In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares in the company, valued at $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 37.40% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Doximity
Hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its holdings in shares of Doximity by 4.5% in the 4th quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company’s stock valued at $598,159,000 after purchasing an additional 485,102 shares in the last quarter. FMR LLC raised its holdings in shares of Doximity by 30.5% in the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after purchasing an additional 1,598,602 shares in the last quarter. State Street Corp raised its holdings in shares of Doximity by 2.5% in the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company’s stock valued at $160,947,000 after purchasing an additional 88,922 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Doximity by 19.8% in the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock valued at $124,503,000 after purchasing an additional 472,565 shares in the last quarter. Finally, Los Angeles Capital Management LLC raised its holdings in shares of Doximity by 33.7% in the 4th quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company’s stock valued at $46,466,000 after purchasing an additional 219,448 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
See Also
Receive News & Ratings for Doximity Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Doximity and related companies with MarketBeat.com’s FREE daily email newsletter.